TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07929870: A Prospective, Open Study on the Safety and Effectiveness of CellBooster® Glow (Stabilized Hyaluronic Acid-based Complex) on Healthy Participants

Sponsor: Suisselle · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 60 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$4,024,800

Rescue Site Savings

+$2,657,400

Unlock Full NCT07929870 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07929870 Rescue Dossier →